ONTX Annual Current Liabilities
$9.22 M
+$1.17 M+14.59%
31 December 2023
Summary:
As of January 21, 2025, ONTX annual total current liabilities is $9.22 million, with the most recent change of +$1.17 million (+14.59%) on December 31, 2023. During the last 3 years, it has fallen by -$801.00 thousand (-7.99%).ONTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONTX Quarterly Current Liabilities
$9.42 M
+$202.00 K+2.19%
31 March 2024
Summary:
As of January 21, 2025, ONTX quarterly total current liabilities is $9.42 million, with the most recent change of +$202.00 thousand (+2.19%) on March 31, 2024. Over the past year, it has increased by +$202.00 thousand (+2.19%).ONTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONTX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.6% | +2.2% |
| 3 y3 years | -8.0% | +2.2% |
| 5 y5 years | +9.3% | +2.2% |
ONTX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -63.7% | -66.6% |
Onconova Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $9.42 M(+2.2%) |
| Dec 2023 | $9.22 M(+14.6%) | $9.22 M(-4.7%) |
| Sept 2023 | - | $9.67 M(+11.6%) |
| June 2023 | - | $8.67 M(-6.0%) |
| Mar 2023 | - | $9.22 M(+14.6%) |
| Dec 2022 | $8.05 M(+31.6%) | $8.05 M(+9.7%) |
| Sept 2022 | - | $7.34 M(+13.6%) |
| June 2022 | - | $6.46 M(+8.6%) |
| Mar 2022 | - | $5.95 M(-2.7%) |
| Dec 2021 | $6.12 M(-39.0%) | $6.12 M(-13.0%) |
| Sept 2021 | - | $7.03 M(-6.3%) |
| June 2021 | - | $7.50 M(+2.4%) |
| Mar 2021 | - | $7.33 M(-26.9%) |
| Dec 2020 | $10.02 M(+20.9%) | $10.02 M(+7.9%) |
| Sept 2020 | - | $9.29 M(+6.2%) |
| June 2020 | - | $8.75 M(+26.6%) |
| Mar 2020 | - | $6.91 M(-16.7%) |
| Dec 2019 | $8.29 M(-1.7%) | $8.29 M(+1.1%) |
| Sept 2019 | - | $8.20 M(-6.3%) |
| June 2019 | - | $8.75 M(+4.0%) |
| Mar 2019 | - | $8.41 M(-0.3%) |
| Dec 2018 | $8.44 M | $8.44 M(+2.8%) |
| Sept 2018 | - | $8.21 M(-17.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $9.98 M(-5.5%) |
| Mar 2018 | - | $10.55 M(+5.8%) |
| Dec 2017 | $9.98 M(-1.8%) | $9.98 M(+11.0%) |
| Sept 2017 | - | $8.99 M(-8.9%) |
| June 2017 | - | $9.86 M(-0.2%) |
| Mar 2017 | - | $9.88 M(-2.7%) |
| Dec 2016 | $10.16 M(+33.6%) | $10.16 M(+12.8%) |
| Sept 2016 | - | $9.01 M(-1.0%) |
| June 2016 | - | $9.10 M(+19.0%) |
| Mar 2016 | - | $7.64 M(+0.5%) |
| Dec 2015 | $7.61 M(-25.9%) | $7.61 M(-12.2%) |
| Sept 2015 | - | $8.66 M(-12.9%) |
| June 2015 | - | $9.94 M(-7.7%) |
| Mar 2015 | - | $10.76 M(+4.9%) |
| Dec 2014 | $10.26 M(-0.8%) | $10.26 M(-21.3%) |
| Sept 2014 | - | $13.04 M(+9.2%) |
| June 2014 | - | $11.95 M(+3.4%) |
| Mar 2014 | - | $11.56 M(+11.8%) |
| Dec 2013 | $10.34 M(-59.3%) | $10.34 M(-30.3%) |
| Sept 2013 | - | $14.83 M(+11.5%) |
| June 2013 | - | $13.31 M(-52.9%) |
| Mar 2013 | - | $28.23 M(+11.2%) |
| Dec 2012 | $25.38 M(+110.1%) | $25.38 M |
| Dec 2011 | $12.08 M | - |
FAQ
- What is Onconova Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Onconova Therapeutics?
- What is Onconova Therapeutics annual current liabilities year-on-year change?
- What is Onconova Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Onconova Therapeutics?
- What is Onconova Therapeutics quarterly current liabilities year-on-year change?
What is Onconova Therapeutics annual total current liabilities?
The current annual current liabilities of ONTX is $9.22 M
What is the all time high annual current liabilities for Onconova Therapeutics?
Onconova Therapeutics all-time high annual total current liabilities is $25.38 M
What is Onconova Therapeutics annual current liabilities year-on-year change?
Over the past year, ONTX annual total current liabilities has changed by +$1.17 M (+14.59%)
What is Onconova Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ONTX is $9.42 M
What is the all time high quarterly current liabilities for Onconova Therapeutics?
Onconova Therapeutics all-time high quarterly total current liabilities is $28.23 M
What is Onconova Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ONTX quarterly total current liabilities has changed by +$202.00 K (+2.19%)